Disclosures for "The Spectrum of Neurological Complications in Dengue: The Neuroinfections Emerging in the Americas Study (NEAS) in Colombia"
-
Ms. Villegas has nothing to disclose.
-
Dr. Medina has nothing to disclose.
-
Dr. Acero-Garces has nothing to disclose.
-
Dr. Vallejo Cajigas has nothing to disclose.
-
Thanya Lagos has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Katherine Claros has nothing to disclose.
-
Dr. Dominguez Penuela has nothing to disclose.
-
Martha Moyano has nothing to disclose.
-
Lyda Osorio has nothing to disclose.
-
Beatriz Parra has nothing to disclose.
-
The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
-
Author has nothing to disclose
-
Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.